Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Teaching Course 3304

Dystonia: Diagnosis, Pathophysiology and Treatment

Tuesday, October 7, 2025
16:30 - 18:00 | Room TBD

In this session, the faculty will discuss the definition and classification, the etiology including genetics and current approach to treatment of dystonia.


Chairs:

Francesca Morgante, United Kingdom
Marie Vidailhet, France

Presenters:

Updates on Diagnosis
Hyder Jinnah, USA

Genetics of Dystonia
Lara Lange, USA

Treatment of Dystonia
Sanjay Pandey, India

CSPC Liaisons:

Pramod Pal, India
Francesca Morgante, United Kingdom

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Discuss the definition and classification of dystonia
  2. Identify genetic causes of isolated dystonias and of selected combined treatable dystonias
  3. Discuss oral medications, identify the muscles to treat with botulinum toxin and select patients for functional neurosurgery

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Researcher / Basic Science

Education Level

Beginner / Foundational
Intermediate / Experienced

Focus

Clinical